Clinical Trials Logo

Clinical Trial Summary

This is a observational study to identify the key factor associated with vasospastic angina and to explore the prognosis of the participants. The study will recruit 400 patients with vasospastic angina, 400 healthy controls and 400 patients with acute myocardial infarction. Next generation sequencing, metabolome and proteomics will be performed in these participants.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05282511
Study type Observational
Source Tongji Hospital
Contact Yang Sun, MD, PhD
Email sunyang.7@163.com
Status Recruiting
Phase
Start date January 2012
Completion date December 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04827498 - Myocardial Ischemia Without Obstructive Coronary Stenoses
Completed NCT02087007 - A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina Phase 3
Recruiting NCT05294887 - Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Phase 4
Recruiting NCT05313919 - Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis
Recruiting NCT04674449 - iCorMicA - Stratified Medicine in Angina N/A
Completed NCT02094469 - Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina Phase 3
Recruiting NCT02180971 - Multidetector Coronary CT In Vasospastic Angina N/A
Completed NCT00602017 - Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions N/A
Completed NCT00601302 - Bioequivalency Study of Amlodipine Tablets Under Fed Conditions N/A